Antimicrobial Resistance among Community-Acquired Uropathogens in Mashhad, Iran

Table 3

Univariate analysis of the risk factor for community-acquired urinary tract infections caused by ciprofloxacin-resistant E. coli strains.

Characteristics	Ciprofloxacin		B	OR (95% CI)	value	TMP-SMX		B	OR (95% CI)	value
		Resistant				Sensitive	Resistant				Sensitive
Age group (years)	0–14	2 [12]	6 (75)	0.081	1.084 (0.496–2.370)	0.839	4 (33.3)	8 (66.7)	0.721	2.057 (1.066–3.972)	0.032
15–64	40 (43)	53 (57)	46 (41.4)				65 (58.6)
≥65	7 (36.8)	12 (63.2)	19 (63.3)				11 (36.7)
Gender (female)		40 (40)	59 (59.6)	0.101	1.106 (0.427–2.869)	0.835	61 (48)	66 (52)	−0.732	0.481 (0.195–1.186)	0.112
Diabetes mellitus		14 (58.3)	10 (41.7)	0.432	1.540 (0.473–5.011)	0.473	12 (46.2)	14 (53.8)	−0.049	0.952 (0.350–2.589)	0.924
History of previous episodes of UTIs		35 (46.7)	40 (53.3)	0.714	2.042 (0.904–4.609)	0.068	46 (54.1)	56 (54.9)
Exposure to antibiotics in the past 3 months		30 (54.5)	25 (45.5)	1.063	2.894 (1.333–6.285)	0.007	34 (44.2)	43 (55.8)	0.087	1.091 (0.566–2.102)	0.796
History of hospital admission in the past 3 months		9 (64.3)	5 (35.7)	1.077	2.937 (0.916–9.419)	0.070	8 (50)	8 (50)	0.292	1.339 (0.474–3.787)	0.582

TMP-SMX: trimethoprim-sulfamethoxazole.